Results 41 to 50 of about 12,067 (119)

A study of the prevalence of diarrhoeagenic Escherichia coli in children from Gwagwalada, Federal Capital Territory, Nigeria

The Pan African Medical Journal, 2014
INTRODUCTION: Diarrhoeagenic Escherichia coli (DEC) are major causes of diarrhoea in Nigeria. This study was conducted to determine the prevalence of diarrhoea caused by DEC within the Federal Capital Territory, Abuja, Nigeria.
Adebola Onanuga, Oluwatoyin Igbeneghu, Adebayo Lamikanra   +2 more
doaj   +1 more source

Zoonotic Escherichia coli

Acta Veterinaria Scandinavica, 2002
Escherichia coli is a normal inhabitant of the gastrointestinal tract of all warm-blooded animals, but variants of this species is also among the important etiological agents of enteritis and several extraintestinal diseases. The E.
Wasteson Yngvild
doaj   +1 more source

Whole Genome Sequencing of an Unusual Serotype of Shiga Toxin–producing Escherichia coli

Emerging Infectious Diseases, 2013
Shiga toxin–producing Escherichia coli serotype O117:K1:H7 is a cause of persistent diarrhea in travelers to tropical locations. Whole genome sequencing identified genetic mechanisms involved in the pathoadaptive phenotype.
Tim Dallman, Lisa Cross, Chloe Bishop, Neil Perry, Bente Olesen, Kathie A. Grant, Claire Jenkins   +6 more
doaj   +1 more source

Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype

Scientific Reports, 2018
Shiga toxin (Stx) is the key virulent factor in Shiga toxin-producing Escherichia coli (STEC). To date, three Stx1 subtypes and seven Stx2 subtypes have been described in E. coli, which differed in receptor preference and toxin potency.
Xiangning Bai, Shanshan Fu, Ji Zhang, Ruyue Fan, Yanmei Xu, Hui Sun, Xiaohua He, Jianguo Xu, Yanwen Xiong   +8 more
doaj   +1 more source

Tamoxifen blocks retrograde trafficking of Shiga toxin 1 and 2 and protects against lethal toxicosis

Life Science Alliance, 2019
This study reports an unexpected role of late endosome–lysosome fusion in early endosome-to-Golgi trafficking of Shiga toxins and identifies tamoxifen to be a potent inhibitor of Shiga toxicosis. Shiga toxin 1 (STx1) and 2 (STx2), produced by Shiga toxin–
Andrey S Selyunin, Steven Hutchens, Stanton F McHardy, Somshuvra Mukhopadhyay   +3 more
doaj   +1 more source

Isolation of Shiga toxin-producing Escherichia coli from raw milk in Kermanshah, Iran

Iranian Journal of Microbiology, 2013
Background and Objectives: Infectious diarrhoeal diseases are great problem throughout the world and are responsible for considerable morbidity and mortality.
Pantea Mohammadi, Ramin Abiri, Mansour Rezaei, Siavosh Salmanzadeh-Ahrabi   +3 more
doaj  

Aplikasi Kandidat Pemindai untuk Diagnosis Gen Shiga like toxin-2 dari Escherichia coli O157:H7 (PROBE APLICATION TO DIAGNOSTIC PROGRAME OF SHIGA LIKE TOXIN-2 (STX2) GEN FROM ESCHERICHIA COLI O157:H7)

Jurnal Veteriner, 2013
A Shiga-like toxin producing Escherichia coli O157:H7 has been detected in cattle fecal sample, atbeef, and human as well as in beef and indicating that the agent is a harmful zoonosis bacteria. Geneticanalysis of Shiga toxin Escherichia coli (STEC) gene
I Wayan Suardana, I Nengah Sujaya, Wayan Tunas Artama   +2 more
doaj  

Shiga Toxin–producing Escherichia coli, Idaho

Emerging Infectious Diseases, 2007
Vivian Marie Lockary, Richard Frederick Hudson, Christopher Lawrence Ball   +2 more
doaj   +1 more source

Primary Thrombotic Microangiopathy in Pediatric Patients

Global Pediatric Health
Background . Primary thrombotic microangiopathy includes hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli , atypical hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura. Methodology .
Andrés David Aranzazu Ceballos MD, Lina María Martínez Sánchez MSc, Ana Paulina Pamplona Sierra MD, Daniela Vergara Yánez MD, Liliana Franco Hincapié PhD, Richard Baquero Rodriguez MD   +5 more
doaj   +1 more source

Inter-society consensus on the management of acute bloody diarrhea and shiga toxin-producing Escherichia coli infection in the molecular microbiology era. [PDF]

Ital J Pediatr
Ardissino G, Agostiniani R, Benatti SV, Bonardi S, Brasca M, Brigotti M, Callegaro A, Centrone F, Chironna M, Clerici P, Daprai L, Dato L, Debertolis G, Decastelli L, Decembrino L, Nicola L, Mauro GD, Folli F, Gabrielli L, Gazzola A, La Porta E, Losio MN, Lo Vecchio A, Luini M, Magistrali CF, Mancuso MC, Marcantoni C, Morabito S, Nicolini G, Norsa L, Pasini A, Picozzi C, Principi N, Romano C, Ruzza ML, Zampogna S.   +35 more
europepmc   +1 more source